Tech Company M&A Transactions

BioFX Laboratories Acquisition

BioFX Laboratories was acquired by SurModics. The transaction was announced on 8/13/2007. SurModics disclosed that the acquisition price was $22.7 million.

Transaction Overview

Company Name
Acquired By
Announced On
8/13/2007
Transaction Type
M&A
Amount
$22,700,000
M&A Terms
The transaction consists of $11.3 million in cash at closing and up to an additional $11.4 million in cash upon the successful achievement of specified revenue targets.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10715 Red Run Blvd. 114
Owings Mills, MD 21117
USA
Email Address
Not Recorded
Overview
BioFX is a leading supplier of innovative immunoreagents for biomedical research and medical diagnostic markets. BioFX has established a commitment to innovation, quality, performance, and technical service.
Profile
BioFX Laboratories LinkedIn Company Profile
Social Media
BioFX Laboratories Company Twitter Account
Company News
BioFX Laboratories News
Facebook
BioFX Laboratories on Facebook
YouTube
BioFX Laboratories on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charles Hewitt
  Charles Hewitt LinkedIn Profile  Charles Hewitt Twitter Account  Charles Hewitt News  Charles Hewitt on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/13/2007: Restoration Robotics venture capital transaction
Next: 8/13/2007: Aequus Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary